7th Circ. Won't Revisit Eyedrop Suit Against Merck, Others
The Seventh Circuit refused Friday to reconsider en banc its decision stripping class certification from glaucoma sufferers who said that eyedrop containers by Merck, Allergan and others dispense too-large drops, forcing...To view the full article, register now.
Already a subscriber? Click here to view full article